2024.09.27
*Announcement* Comprehensive Collaborative Agreement with Pharmaceutical Research Institute, Pharmaceutical Division of UBE Co.
The Institute and the Pharmaceutical Research Institute, Pharmaceutical Division of UBE Co., Ltd. have entered into a Comprehensive Collaborative Agreement to promote research activities and disseminate the results of innovative medical technologies such as cell design technology and genome editing technology at both institutions, thereby contributing to the development of academic research and the promotion of development for social implementation in Japan, Comprehensive Collaborative Agreement concluded.
On Thursday, September 26, 2024, a collaboration agreement ceremony was held at the Institute of Pharmaceutical Research, Pharmaceutical Division, UBE Corporation, where Dr. Tamada, Director of the Institute, and Dr. Tokunaga, Director of the Institute, signed the agreement.
(Reference) Pharmaceutical Research Institute, Pharmaceutical Division, UBE Co.
https://www.ube.co.jp/ube/jp/rd/pharmaceuticals_detail.html
